<DOC>
	<DOCNO>NCT00605930</DOCNO>
	<brief_summary>This study intend study safety tolerance combination pyruvate , creatine , niacinamide 6 month patient PSP .</brief_summary>
	<brief_title>A Pilot Clinical Trial Pyruvate , Creatine , Niacinamide Progressive Supranuclear Palsy .</brief_title>
	<detailed_description>There effective symptomatic biologic treatment progressive supranuclear palsy ( PSP ) , relatively rare neurodegenerative disease present late life relentless progressive postural balance disturbance , non-levodopa responsive parkinsonism , supranuclear vertical gaze palsy , pseudobulbar palsy , frontal behavioral dysexecutive symptom . In light currently propose etiopathogenic mechanism PSP base successful experiment inhibit cellular neurotoxicity , hypothesize preservation brain energy homeostasis may allow endogenous neuroprotective mechanism reverse impede free radical injury neurotoxic event lead neurodegeneration disease . An emerge literature describe neuroprotective effect pyruvate , ( neuronal energy fuel free radical scavenger ) ; niacinamide , ( boost cofactor NAD ) , creatine , ( buffer selectively parcel cellular energy utilization ) various animal model brain injury degeneration . Ajay Verma et al . demonstrate synergistic neuroprotective effect three nutrient various neural injury model . We thus propose use nutrient novel safe neuroprotective approach treat PSP patient . This randomized , double-blind , placebo , control pilot study test safety tolerance nutrient combination 6 month patient PSP , measure transport across blood brain barrier . In addition clinical neuropsychological outcome measure , brain creatine also evaluate use magnetic resonance spectroscopy therapy</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>All subject must meet clinically definite probable NINDSSPSP PSP diagnostic research criterion include presence postural instability disease onset , well supranuclear vertical ophthalmoparesis . All subject must able tolerate oral feeding ambulatory All subject caregiver must able read understand consent Any contraindication use pyruvate , creatine , niacinamide presence medical condition reasonably expect subject patient unwarranted risk require frequent change medication . Pregnancy , nursing , lack effective contraception , still childbearing age . History prior sever traumatic brain injury severe neurologic psychiatric condition , psychosis , stroke , multiple sclerosis , spinal cord injury , interfere outcome evaluation , opinion local principal investigator Subject unable discontinue prohibit medication , include antiparkinsonian medication potential neuroprotective effect amantadine , deprenyl , vitamin E supplement &gt; 400 IU per day .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Progressive Supranuclear Palsy</keyword>
	<keyword>PSP</keyword>
	<keyword>Nutriceutical</keyword>
	<keyword>Pyruvate</keyword>
	<keyword>Creatine</keyword>
	<keyword>Niacinamide</keyword>
</DOC>